A clinical low testosterone trial began to test the hypotheses that testosterone treatment of elderly men whose serum testosterone concentrations are unequivocally low – and who have symptoms and objectively measured abnormalities in at least one of five areas that could be due to low testosterone (physical or sexual function, vitality, cognition, and anemia) – will result in more favorable changes in those abnormalities than placebo treatment (the trial began in 2009).
The low testosterone trial is using the drug AndroGel® (testosterone gel). In addition, two additional trials have been incorporated into the low testosterone trial. The low testosterone trial will also study:
- The Cardiovascular Trial will examine if testosterone treatment results in more favorable changes in cardiovascular risk factors, compared to placebo.
- The Bone Trial will test the hypothesis that testosterone treatment will increase volumetric trabecular bone mineral density (vBMD) of the lumbar spine as measured by quantitative computed tomography (QCT), compared with placebo treatment.
The call for more low T or more low testosterone studies is based on the recent studies (see Low T Lawsuit ) published by NIH and the VA. These low testosterone studies raised concerns that low T therapy or low testosterone therapy may possibly be linked to cardiovascular events in men.
In addition, the FDA started to investigate low testosterone Low T therapy. The FDA investigation involves recent reports that Low T therapy may be associated with a possible risk of stroke, heart attack, and death in men taking FDA-approved testosterone products (e.g., androgel etc).
Some of the potential problems that may be caused by low T or low testosterone therapy may include:
- Stroke, which occurs when a blood clot reaches the brain and restricts oxygen supply
- Pulmonary embolism, which happens when a blood clot lodges in the lungs
- Blood Clot in the Deep Veins (Deep Vein Thrombosis or DVT)
- Myocardial infarction (Heart Attack), commonly known as a heart attack – a sudden loss of blood flow in the heart
- Arrhythmia, an irregular heartbeat
- Transient ischemic attacks, or “mini-strokes,” as they are commonly called
- Death
If you or your loved one has suffered a heart attack or stroke while on Androgel®, Androderm®, Fortesta®, Axiron®, Testim®, Bio-T-Gel®, Delatestryl®, Depo-Testosterone®, Striant®, and Testopel®– and you have any of these symptoms while on low testosterone or low t therapy and want to talk to a Low T lawyer and/or file a low testosterone lawsuit or low t lawsuit, contact us.
At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases. If you or a man you know suffered a stroke, pulmonary embolism, heart attack, stroke, death or another serious cardiac event while undergoing low testosterone therapy or low T therapy (e.g., androgel et al.) and would like your case evaluated, contact our office at 1.844.329.5955.
WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS